Healthcare
-
Elizabeth Holmes: How the Theranos Founder’s Fraud Ended in Prison
Elizabeth Holmes, the founder of the blood-testing startup Theranos, was once hailed as a visionary and a symbol…
-
Cost-Effectiveness Analysis: The Economic Framework That Evaluates
WASHINGTON, July 21 — When a patient’s doctor chooses one treatment over another, the decision rarely rests on…
-
Metabolic Cancer Drugs Market Shows Strong Economic Growth
LOS ANGELES, July 17 — A small California biotechnology company is quietly advancing a new approach to cancer…
-
Erasca Founders Lead UCSF Spinout to Public Company Status
SAN DIEGO, July 15 — When Jonathan E. Lim founded Erasca in 2018, he was already carrying a…
-
CSPC, AstraZeneca AI Drug Deal Signals Continued Growth
SHANGHAI, July 13 — The question that has quietly nagged at the pharmaceutical industry for years is whether…
-
Chinese biotech exports hit record $110 billion in H1 2026
BEIJING, July 13 — Cross-border deals for innovative drugs originating from China have reached a record US$110 billion…
-
Global buyers from 20 nations, led by US, UK, France, Italy
BEIJING, July 13 — The story begins with a number that stopped the pharmaceutical world cold: US$110 billion…
-
Alzheimer’s Drug Market Projected to Hit $15 Billion by 2030
WASHINGTON, July 10 — For the millions of American families touched by Alzheimer’s disease, the conversation around treatment…
-
DOJ Launches Major Corporate Fraud Initiative Targeting Banks And Healthcare
WASHINGTON, July 9 — The Department of Justice today announced a sweeping new initiative targeting corporate fraud, with…
-
Global Longevity Market: Economic Impact and Growth Since 2020
BASEL, July 8 — Against the backdrop of a rapidly aging global population, the business of extending human…
-
CAR-T Therapy Market Soars with $3.9B in Sales, U.S. Leads Growth
ISLAMABAD, July 7 — The global market for CAR-T cell therapy, a personalized cancer treatment that reprograms a…
-
GeneDx’s Strategic Shifts Spark Acquisition Dispute
NEW YORK and NEW ORLEANS, July 4 — A securities class action lawsuit against GeneDx Holdings Corp. has…
-
U.S. Leads in Technology, Finance, Healthcare, and Aerospace Sectors
Every generation of Americans has been told the same thing about their country: that it is an exceptional…
-
Inventiva shareholders approve governance measures at annual meeting
DAIX, France, July 2 — Inventiva reported the results of its Combined Shareholders’ General Meeting held June 30,…
-
GRAIL Faces Fraud Lawsuit Over Misrepresented NHS-Galleri Trial Results
New York, June 30 — The blood test had been GRAIL’s holy grail. A simple draw, a screen…
-
Hunterbrook Capital Alleges Ensign Group Understaffed Nursing Homes for Profit
Every dollar The Ensign Group receives from Medicare and Medicaid comes with strings attached. Those strings are supposed…
-
Tilray Brands Acquires HelloMD, Creating Closed-Loop Medical Cannabis System
Canadian medical cannabis patients will soon find themselves inside a closed loop. Tilray Brands now owns HelloMD, the…
-
Open-source list offers free cloud tiers for developers building healthcare software
Behind every hospital patient portal, every lab-result dashboard, every appointment-booking screen a doctor clicks open, there is a…
-
Autos and Healthcare lead Nifty past 24,200 as crude stays near $69
MUMBAI, June 25 — India’s benchmark Nifty 50 index closed above a significant mark for the first time,…
-
Nifty crosses 24,200 as falling crude boosts auto and healthcare stocks
For India’s auto and pharma companies, the arithmetic just got simpler. Crude oil hovering near $69 a barrel…
-
BOLD restarts, MNPR NDA on track, GALT soars on FDA news
NEW YORK, June 24 — On the ground, biotech investors are witnessing a significant surge in stock prices,…
-
Biotech sector surges as BOLD restarts, MNPR advances, GALT rises
Three biotech companies are putting real money on the line today. BOLD has restarted operations. MNPR’s New Drug…
-
Hunterbrook Report Questions Ensign Group’s Care and Revenue Structure
Wall Street is still digesting the fallout from June 8, the day a single research report erased hundreds…
-
Ernexa Therapeutics Targets Q3 2026 IND Filing for ERNA-101
CAMBRIDGE, Mass., June 17 — Ernexa Therapeutics Inc. has announced significant progress in the development of its lead…
Most read
-
Food & Hospitality Malaysia in Kuala Lumpur 2027
-
Yandex Data Center Shut Down After Reported Drone Attack in Moscow
-
The Malaysian International Food & Beverage Trade Fair in Kuala Lumpur 2027
-
ARCHIDEX in Kuala Lumpur 2027
-
PC Shipments Plunge 20.1% in Q3 2026, Sharpest Drop Since Q1 2023 Amid Prolonged Downturn
-
Why Petroleum at $117 Per Barrel Squeezes Corporate Margins and Markets
-
Anthropic IPO Delay Exposes $3.6 Trillion AI Valuation Gap
-
Dow Jumps 530 Points to Record 52,496 as Healthcare and Small Caps Lead Broad Rally
-
US Earnings Season Intensifies as High Interest Rates Pressure Tech Valuations
-
The Path to Profitability in the Age of Massive Artificial Intelligence Spending
-
EASA Urged to Strengthen Fatigue Rules as Pilot Reporting Systems Collapse Across Europe
-
How Navi Mumbai’s Airport Capacity and Terminal Redevs Reshape Mumbai Aviation
-
Boeing’s 737-10 Certification Faces Profit Test in Q3 Earnings
-
How Riyadh Air Reconfigures Operations Amid Regional Conflict
-
McKinsey: Pilot and Aircraft Shortages Now Cap Business Aviation Growth
-
Real Estate Price Cuts Signal Buyer Power in Stagnant U.S. Housing Market
-
NAHB CEO: 7.4% Mortgage Rates ‘Eating Up’ Housing News as Index Hits 14-Year Low
-
How Federal National Mortgage Association Generates Billions Amid Market Risks
-
Fannie Mae Faces Market Volatility as Housing Distress and Equity Risks Mount
-
El Niño and Iran War Drive Agricultural Commodity Prices to New Highs
-
ICE Brent Hovers Near $110 as Middle East Tensions Keep Risk Premium High
-
How Agricultural Policy Uses Uniform Formulas to Distribute $8B in Farm Relief
-
Donald Trump Announces $8 Billion Harvest Fuel Relief Program for U.S. Farmers
-
Dairy Dominates Tulare County’s $9.1B Agriculture Economy, Amid Climate and Trade Risks